Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welcef 1g
Welcef 1g is a broad-spectrum cephalosporin antibiotic containing Ceftazidime 1g, formulated for the treatment of serious bacterial infections. It is highly effective against drug-resistant Gram-negative bacteria, including Pseudomonas aeruginosa, making it an essential choice for hospital-acquired and complicated infections.
Uses of Welcef 1g
Welcef 1g is indicated for the treatment of:
Severe respiratory tract infections, including pneumonia
Urinary tract infections (complicated & uncomplicated)
Bacterial meningitis
Septicemia and bloodstream infections
Bone and joint infections
Intra-abdominal infections, including peritonitis
Skin and soft tissue infections
Benefits of Welcef 1g
Broad-Spectrum Antibacterial Action: Effective against resistant Gram-negative and Gram-positive bacteria
Highly Effective Against Pseudomonas Aeruginosa: Preferred in critical care settings
Rapid Bactericidal Effect: Ensures quick infection control and symptom relief
Well-Tolerated & Safe: Minimal side effects with excellent efficacy
Ideal for Severe & Complicated Infections
Mechanism of Action of Welcef 1g
Ceftazidime works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), leading to cell lysis and bacterial death. Its enhanced stability against β-lactamases makes it highly effective against resistant bacterial strains.